Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

Advances in sequencing technology have made multigene testing, or “panel testing,” a practical option when looking for genetic variants that may be associated with a risk of breast cancer. In June

Integrating a Polygenic Risk Score into a clinical setting would impact risk predictions in familial breast cancer

A research-based gene panel to investigate breast, ovarian and prostate cancer genetic risk

Spectrum and management of breast cancer patients with variant of uncertain significance mutations at a tertiary care centre in North India - ecancer

Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus

Construction of stemness gene score by bulk and single-cell transcriptome to characterize the prognosis of breast cancer

Software-assisted manual review of clinical NGS data: an alternative to routine Sanger sequencing confirmation with equivalent results in >15,000 hereditary cancer screens

Disease Spectrum of Breast Cancer Susceptibility Genes

PDF) Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families

An overview of genetic services delivery for hereditary breast cancer

Who needs breast cancer genetics testing?

Frontiers Disease Spectrum of Breast Cancer Susceptibility Genes